Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year free cash flow growth rate
3Y CAGR
+137.9%/yr
Annual compound
Percentile
P83
Within normal range
vs 3Y Ago
13.5x
Strong expansion
Streak
1 yr
Consecutive declineStable
| Period | Value |
|---|---|
| 2025 | 70.08% |
| 2024 | 73.35% |
| 2023 | 10.93% |
| 2022 | 5.21% |
| 2021 | -113.83% |
| 2020 | -106.27% |
| 2019 | 0.00% |